Associated malignancies in patients with Waldenström's macroglobulinemia and their kin

Clinical Lymphoma, Myeloma and Leukemia

Volumn 11, Issue 1, 2011, Pages 88-92

  Hanzis, Christina ^a   Ojha, Rohit P ^b   Hunter, Zachary ^a   Manning, Robert ^a   Lewicki, Megan ^a   Brodsky, Philip ^a   Ioakimidis, Leukothea ^a   Tripsas, Christina ^a   Patterson, Christopher J ^a   Sheehy, Patricia ^c   Treon, Steven P ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Division of Medical Sciences   (United States)

^c Harvard Medical School ^*

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; B CELL LEUKEMIA; BLADDER CANCER; BREAST CANCER; COLON CANCER; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY ASSESSMENT; FAMILY HEALTH; FEMALE; GYNECOLOGIC CANCER; HEMATOLOGIC MALIGNANCY; HUMAN; KIDNEY CANCER; LARGE CELL LYMPHOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; MYELOID LEUKEMIA; PROSTATE CANCER; SKIN CANCER; T CELL LEUKEMIA; THYROID CANCER; WALDENSTROEM MACROGLOBULINEMIA;

EID: 79953699058     PISSN: 21522650     EISSN: 21522669     Source Type: Journal    
DOI: 10.3816/CLML.2011.n.016     Document Type: Conference Paper

References (25)

1. Owen RG, Treon SP, Al-Katib A, et al. Clinicopathological definition of Waldenström's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenström's macroglobulinemia. Semin Oncol 2003; 30:110-5. (Pubitemid 36506291)
2. Kyle RA, Benson J, Larson DR, et al. IgM monoclonal gammopathy of undetermined significance and smoldering Waldenstrom's Macroglobulinemia. Clin lymphoma Myeloma 2009; 9:17-8.
3. Massari R, Fine JM, Metais R. Waldenstrom's macroglobulinaemia observed in two brothers. Nature 1962; 196:176-8.
4. Bjornsson OG, Arnason A, Gudmunosson S, et al. Macroglobulinaemia in an Icelandic family. Acta Med Scand 1978; 203:283-8. (Pubitemid 8323240)
5. Renier G, Ifrah N, Chevailler A, et al. Four brothers with Waldenström's macroglobulinemia. Cancer 1989; 64:1554-9.
6. Treon SP, Hunter ZR, Aggarwal A, et al. Characterization of familial Waldenstrom's macroglobulinemia. Ann Oncol 2006; 17:488-94.
7. McMaster ML, Csako G, Giambarresi TR, et al. Long-term evaluation of three multiple-case Waldenstrom macroglobulinemia families. Clin Cancer Res 2007; 13:5063-9. (Pubitemid 47502071)
8. Royer RH, Koshiol J, Giambarresi TR, et al. Differential characteristics of Waldenström macroglobulinemia according to patterns of familial aggregation. Blood 2010; 115:4464-71.
9. Hunter Z, Hanzis C, Ioakimidis T, et al. Genome Wide Association Studies of Familial Waldenstrom's Macroglobulinemia (WM) Reveals a Loss of GSTM1 Is Common in Families with a History of B-Cell Disorders but Not in Those with a History Specific for WM. Blood 2009; 114: (abstract 762).
10. Kristinsson SY, Bjorkhom M, Goldin LR, et al. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden. Blood 2008; 12:3052-6.
11. Varettoni M, Tedeschi A, Pascutto C. Risk of second cancers in Waldenstrom Macroglobulinemia: a population-based study from northern Italy. Blood 2009; 114: (abstract 3951).
12. Travis LB, Curtis RE, Hankey BF, et al. Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst 1992; 84:1442-7.
13. Landgren O, Pfeiffer RM, Stewart L, et al. Risk of second malignant neoplasms among lymphoma patients with a family history of cancer. Int J Cancer 2007; 120:1099-2.
14. Subramanian S, Goldstein DP, Parlea L, et al. Second primary malignancy risk in thyroid cancer survivors: A systemic review and meta-analysis. Thyroid 2007; 17:1277-88.
15. Choueiri TK, Baz RC, McFadden CM, et al. An association between renal cell carcinoma and multiple myeloma: A case series and clinicalimplications. BJU Int 2008; 101:712-5. (Pubitemid 351269993)
16. Larson AA, Leachman SA, Eliason MJ, et al. Population-based assessment of non-melanoma cancer risk in relatives of cutaneous melanoma probands. J Invest Dermatol 2007; 127:183-8. (Pubitemid 46005677)
17. Dong C, Hemminki K. Second primary neoplasms among 53,159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: A search for common mechamisms. Br J cancer 2001; 85:997-1005. (Pubitemid 33016003)
18. Kristinsson SY, Golden LR, Bjorkholm M, et al. Risk of solid tumors and myeloid hematological malignancies among first-degree relatives of patients with monoclonal gammopathy of undetermined significance. Haematologica 2009; 94:1179-81.
19. Kristinsson SY, Goldin LR, Bjorkholm M, et al. Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden. Int J Cancer 2009; 125:2147-50.
20. Schop RF, Jalal SM, Van Wier SA, et al. Deletions of 17p13.1 and 13q14 are uncommon in Waldenstrom macroglobulinemia clonal cells and mostly seen at time of disease progression. Cancer Genet Cytogenet 2002; 132:55-60. (Pubitemid 34136052)
21. Chang H, Samiee S, Patterson B, et al. Analysis of IgH translocations, chromosome 13q14 and 17p13.1 (p53) deletions by fluorescence in situ hybridization in Waldenstrom's Macroglobulinemia: a single center study of 22 cases. Leukemia 2004; 18:1160-62. (Pubitemid 38786983)
22. Helzlsouer KJ, Selmin O, Huang HY, et al. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst 1998; 90:512-8. (Pubitemid 28182544)
23. Sørensen M, Autrup H, Tjønneland A, et al. Glutathione S-transferase T1 null-genotype is associated with an increased risk of lung cancer. Int J Cancer 2004; 110:219-24. (Pubitemid 38580394)
24. Nørskov MS, Frikke-Schmidt R, Bojesen SE, et al. Copy number variation in glutathione-S-transferase T1 and M1 predicts incidence and 5-year survival from prostate and bladder cancer, and incidence of corpus uteri cancer in the general population. Pharmacogenomics J 2010; (Epub ahead of press).
25. Leleu X, Soumerai J, Roccaro A, et al. Increased incidence of transformation and MDS in patients with Waldenstrom's macroglobulinemia treated with nucleoside analogs. J Clin Oncol 2009; 27:250-5.